PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18064606-8	2008	L-NAME, PD-98059, and calphostin C increased hENT1 expression without altering protein or mRNA stability.	NG-Nitroarginine Methyl Ester	0-6	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	45-50	
16924660-8	2006	Insulin effect on hENT1 mRNA expression in normal D-glucose was blocked by N(G)-nitro-L-arginine methyl ester (L-NAME, NO synthase inhibitor) and mimicked by S-nitroso-N-acetyl-L,D-penicillamine (SNAP, NO donor).	NG-Nitroarginine Methyl Ester	75-109	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	18-23	
16924660-8	2006	Insulin effect on hENT1 mRNA expression in normal D-glucose was blocked by N(G)-nitro-L-arginine methyl ester (L-NAME, NO synthase inhibitor) and mimicked by S-nitroso-N-acetyl-L,D-penicillamine (SNAP, NO donor).	NG-Nitroarginine Methyl Ester	111-117	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	18-23	
16688763-4	2006	HUVEC from gestational diabetes exhibit reduced SLC29A1 promoter activity when transfected with pGL3-hENT1(-2154) compared with pGL3-hENT1(-1114) constructs, an effect blocked by N(G)-nitro-L-arginine methyl ester (L-NAME, NOS inhibitor), but unaltered by S-nitroso-N-acetyl-L,D-penicillamine (SNAP, NO donor).	NG-Nitroarginine Methyl Ester	179-213	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	101-106	
16688763-4	2006	HUVEC from gestational diabetes exhibit reduced SLC29A1 promoter activity when transfected with pGL3-hENT1(-2154) compared with pGL3-hENT1(-1114) constructs, an effect blocked by N(G)-nitro-L-arginine methyl ester (L-NAME, NOS inhibitor), but unaltered by S-nitroso-N-acetyl-L,D-penicillamine (SNAP, NO donor).	NG-Nitroarginine Methyl Ester	179-213	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	48-55	
16688763-4	2006	HUVEC from gestational diabetes exhibit reduced SLC29A1 promoter activity when transfected with pGL3-hENT1(-2154) compared with pGL3-hENT1(-1114) constructs, an effect blocked by N(G)-nitro-L-arginine methyl ester (L-NAME, NOS inhibitor), but unaltered by S-nitroso-N-acetyl-L,D-penicillamine (SNAP, NO donor).	NG-Nitroarginine Methyl Ester	179-213	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	133-138	
16688763-4	2006	HUVEC from gestational diabetes exhibit reduced SLC29A1 promoter activity when transfected with pGL3-hENT1(-2154) compared with pGL3-hENT1(-1114) constructs, an effect blocked by N(G)-nitro-L-arginine methyl ester (L-NAME, NOS inhibitor), but unaltered by S-nitroso-N-acetyl-L,D-penicillamine (SNAP, NO donor).	NG-Nitroarginine Methyl Ester	215-221	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	48-55	
16688763-5	2006	In cells from gestational diabetes transfected with pGL3-hENT1(-2154), L-NAME increased, but SNAP did not alter promoter activity and hENT1 expression.	NG-Nitroarginine Methyl Ester	71-77	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	57-62	
32858046-7	2020	Effects of adenosine A2 receptors antagonists and ENT1/2 inhibitor were prevented by L-NAME, indicating that nitric oxide production inhibition prevents adenosine from increasing parasitic burden.	NG-Nitroarginine Methyl Ester	85-91	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	50-56